Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LZ7Z
|
|||
| Drug Name |
RG6264
|
|||
| Indication | HER2-positive breast cancer [ICD-11: 2C60-2C65] | Phase 1 | [1] | |
| Company |
Roche/Genentech Basel, Switzerland
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.